We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Remidio's AI Screening for Glaucoma Shows Promise in Study
Remidio's AI Screening for Glaucoma Shows Promise in Study
Remidio, an India-based medical device company that develops eye testing technology using AI and telemedicine integrated devices, announced clinical trial results showing that its Medios Al algorithm can help detect patients with “referable” glaucoma.